NEW YORK (GenomeWeb News) – MRC Technology today announced a collaboration with Renishaw Diagnostics to identify and develop clinical diagnostic tests for infectious diseases.

The collaboration combines Renishaw's multiplex screening technology and expertise in assay development with MRC's experience in developing early-stage research for clinical applications and commercialization, MRC said. The focus will be on identifying and accelerating research with potential in infectious disease diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.